title: Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients.
abstract: OBJECTIVE
  Genome-wide association studies (GWASs) identified that SLC30A8 genetic polymorphism was a risk of type 2 diabetes mellitus (T2DM) in several populations. This study aimed to investigate whether the SLC30A8 rs13266634 and rs16889462 polymorphisms were associated with T2DM susceptibility and repaglinide therapeutic efficacy in Chinese T2DM patients.
  
  
  METHODS
  We conducted a case-control study of 443 T2DM patients and 229 healthy volunteers to identify SLC30A8 rs13266634 and rs16889462 genotypes by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay. Forty-eight patients were randomly selected and underwent an 8-week repaglinide treatment (3 mg/d). Fasting plasma glucose (FPG), postprandial plasma glucose (PPG), glycated hemoglobin (HbAlc), fasting serum insulin (FINS), postprandial serum insulin (PINS), homeostasis model assessment for insulin resistance (HOMA-IR), serum triglyceride, total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-c) and high-density lipoprotein-cholesterol (HDL-c) were determined before and after repaglinide treatment.
  
  
  RESULTS
  SLC30A8 rs13266634 risk C allele frequency was higher in T2DM patients than in healthy controls (P < 0.05). There was a better repaglinide response on FINS (P < 0.05) and PINS (P < 0.01) in patients with rs13266634 CT+TT genotypes compared with CC genotype carriers. Patients with rs16889462 GA genotype showed an enhanced repaglinide efficacy on FPG (P < 0.01), PPG (P < 0.01) and HbAlc (P < 0.05) compared with GG genotype individuals.
  
  
  CONCLUSIONS
  SLC30A8 rs13266634 and rs16889462 polymorphisms were associated with repaglinide therapeutic efficacy in Chinese T2DM patients.
authors.affiliation: Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, Hunan, People's Republic of China.
authors.forename: Qiong
authors.initials: Q
authors.lastname: Huang
authors.forename: Ji-Ye
authors.initials: JY
authors.lastname: Yin
authors.forename: Xing-Ping
authors.initials: XP
authors.lastname: Dai
authors.forename: Jing
authors.initials: J
authors.lastname: Wu
authors.forename: Xiang
authors.initials: X
authors.lastname: Chen
authors.forename: Cai-Shu
authors.initials: CS
authors.lastname: Deng
authors.forename: Min
authors.initials: M
authors.lastname: Yu
authors.forename: Zhi-Cheng
authors.initials: ZC
authors.lastname: Gong
authors.forename: Hong-Hao
authors.initials: HH
authors.lastname: Zhou
authors.forename: Zhao-Qian
authors.initials: ZQ
authors.lastname: Liu
mesh_terms: D000328:Adult; D000368:Aged; D001483:Base Sequence; D002219:Carbamates / Q000627:therapeutic use*; D016022:Case-Control Studies; D027682:Cation Transport Proteins; D002681:China; D017931:DNA Primers; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D055106:Genome-Wide Association Study; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000627:therapeutic use*; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D000075703:Zinc Transporter 8
chemical_list: D002219:Carbamates; D027682:Cation Transport Proteins; D017931:DNA Primers; D007004:Hypoglycemic Agents; D010880:Piperidines; C492522:SLC30A8 protein, human; D000075703:Zinc Transporter 8; C072379:repaglinide
references.citation: PLoS Genet. 2007 Jul;3(7):e115
references.pmid: 17658951
references.citation: Diabetes. 1998 Mar;47(3):345-51
references.pmid: 9519738
references.citation: Biochim Biophys Acta. 2000 May 1;1465(1-2):190-8
references.pmid: 10748254
references.citation: Diabetes. 2008 Oct;57(10):2834-42
references.pmid: 18633108
references.citation: Diabetologia. 2008 Apr;51(4):597-601
references.pmid: 18264689
references.citation: Pharmacotherapy. 1998 Nov-Dec;18(6):1195-204
references.pmid: 9855316
references.citation: Clin Pharmacokinet. 2002;41(7):471-83
references.pmid: 12083976
references.citation: Br J Clin Pharmacol. 2003 Sep;56(3):305-14
references.pmid: 12919179
references.citation: Diabetes Care. 2004 May;27(5):1047-53
references.pmid: 15111519
references.citation: Annu Rev Nutr. 2004;24:151-72
references.pmid: 15189117
references.citation: Diabetologia. 2008 May;51(5):816-20
references.pmid: 18324385
references.citation: Clin Pharmacol Ther. 2005 Jun;77(6):468-78
references.pmid: 15961978
references.citation: Diabetes. 2004 Dec;53 Suppl 3:S113-22
references.pmid: 15561898
references.citation: Science. 2007 Jun 1;316(5829):1341-5
references.pmid: 17463248
references.citation: Nat Genet. 2008 May;40(5):638-45
references.pmid: 18372903
references.citation: Biometals. 2005 Aug;18(4):313-7
references.pmid: 16158222
references.citation: J Biol Chem. 2005 Mar 11;280(10):8793-9
references.pmid: 15613469
references.citation: Clin Chem. 1972 Jun;18(6):499-502
references.pmid: 4337382
references.citation: Nat Cell Biol. 2003 Apr;5(4):330-5
references.pmid: 12640462
references.citation: J Clin Invest. 2005 Jun;115(6):1431-9
references.pmid: 15931378
references.citation: Diabetes Care. 2006 Aug;29(8):1918-20
references.pmid: 16873803
references.citation: Science. 2007 Jun 1;316(5829):1331-6
references.pmid: 17463246
references.citation: Diabetes. 2008 Apr;57(4):1043-7
references.pmid: 18162509
references.citation: Diabetes. 2004 Sep;53(9):2330-7
references.pmid: 15331542
references.citation: PLoS One. 2009 May 25;4(5):e5679
references.pmid: 19479076
references.citation: Metabolism. 2005 Feb;54(2):206-11
references.pmid: 15690315
references.citation: Diabetologia. 1995 Sep;38(9):1025-32
references.pmid: 8591815
references.citation: Clin Pharmacol Ther. 2003 Oct;74(4):380-7
references.pmid: 14534525
references.citation: Diabetes. 2008 Aug;57(8):2226-33
references.pmid: 18469204
references.citation: J Am Coll Nutr. 1998 Apr;17(2):109-15
references.pmid: 9550453
references.citation: Nature. 2007 Feb 22;445(7130):881-5
references.pmid: 17293876
references.citation: Anal Chem. 2000 Feb 15;72(4):711-7
references.pmid: 10701254
references.citation: Diabetologia. 1980 Sep;19(3):174-82
references.pmid: 6997118
references.citation: Diabetes. 2009 Feb;58(2):493-8
references.pmid: 19033397
references.citation: Nat Genet. 2007 Jun;39(6):770-5
references.pmid: 17460697
references.citation: Curr Opin Struct Biol. 1998 Apr;8(2):189-94
references.pmid: 9631292
references.citation: Science. 2007 Jun 1;316(5829):1336-41
references.pmid: 17463249
references.citation: Prog Biophys Mol Biol. 1989;54(2):87-143
references.pmid: 2484976
references.citation: Am J Hum Genet. 2003 Nov;73(5):1162-9
references.pmid: 14574645